IRD filings
Corporate insider profile
Robert E. Gagnon Filing Activity
Latest reported as Chief Financial Officer of Opus Genetics, Inc. (IRD).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$40,657.63
- Latest transaction
- Apr 23, 2026
Affiliated corporations
Reported company relationships
Transaction history
